Long-time Marshall physician Roy Elfrink, M.D., will officially be employed by Fitzgibbon Hospital effective April 1, 2023. Elfrink will be affiliated with Marshall Surgical Associates, a service of Fitzgibbon Hospital, located inside the Fitzgibbon Medical Clinic on the south side of the hospital campus. He and Jason Gault, DO/MBA, will make up the hospital’s general surgery team.
“I’m thrilled that Dr. Elfrink is joining the Fitzgibbon family as an employee effective April 1,” said Angy Littrell, President and CEO of Fitzgibbon Hospital. “Dr. Elfrink has a long legacy of patient care in our surgical suite, so the fact that he has joined us is meaningful for our patients and our hospital. Today’s changing landscape of healthcare and the many ‘headwinds’ providers face in rural Missouri presented this opportunity. I believe our combined resources and years of experience will mutually benefit Fitzgibbon Hospital and our community.”
Dr. Elfrink has provided surgical services for 30 years. For the last few decades he has been co-located with Marshall Surgical Associates but has operated independently, under the name of Elfrink Surgical, LLC. This change should be relatively transparent for patients, with billing services now provided via the hospital rather than his prior management company in Cape Girardeau.
Dr. Elfrink is a board-certified general surgeon and received his medical degree from the University of Missouri School of Medicine in 1987. He served as a general surgery resident at the University of Missouri until 1991 and became the Chief Resident of General Surgery at the University of Missouri – Columbia in 1992. Through numerous medical missions to Haiti, El Salvador, Uganda and Belize, to involvement in numerous local community projects in Marshall, Dr. Elfrink is a valued partner in meeting the health needs of Marshall and surrounding communities.
Marshall Surgical Associates provides many types of surgeries including appendectomy, hernia repair, gallbladder surgery, colonoscopy, biopsies of suspicious lesions or masses, breast cancer surgery, chemotherapy port placement, vasectomy endoscopy and chronic wound treatment.